31 results about "Nutritional Interventions" patented technology

The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.

The present invention relates to a whole nutritional composition and application for balancing intestinal flora structure and improving metabolic syndrome; comprising the first composition, the second composition, the third composition, or the combination of the three compositions. The first composition includes food with the same origin as medicine and food. The second composition includes bitter melon, soluble dietary fiber and oligosaccharides. The third composition includes soluble dietary fiber and oligosaccharides. The present invention provides a nutritional intervention method for targetedly changing intestinal flora, restoring its structural balance, eliminating chronic inflammation, and improving diseases caused by intestinal flora structure disorder, which can be used for Development of drugs, nutritional products, health products, food, etc.

The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.

The invention relates to an enteral nutrition preparation for fat-burning intervention on metabolic syndrome and an application thereof. The preparation is prepared through mixing corns, Chinese yams, buckwheat, soy protein, whey protein, linseed oil, lipoic acid, L-carnitine, minerals, vitamins and other raw materials. The preparation is a special formula for the nutritional intervention on metabolic syndrome of the very low-calorie dietetic therapy, has the effects of promoting steatolysis, promoting weight loss, reducing blood pressure, blood glucose and blood fat, improving the insulin sensitivity and the liver function, and reducing the lean body mass loss, and achieves good prevention and supportive therapeutic efficacies for metabolic syndrome. The preparation can be used for the development of healthcare products and food aimed at promoting weight loss, and has broad application prospects.

The invention discloses a clinical nutrition diagnosis and treatment system which includes a patient information management module, a nutritional risk screening module, a nutritional evaluation module, a nutritional problem analysis module, an intervention implement module, an intervention effect monitoring module and an effect analysis and evaluation module. The nutritional problem analysis module can divide nutritional problems into three levels of nutritional problems. In clinical diagnosis and treatment of nutrition intervention, the information of patients is transmitted through the patient information management module, the nutritional risk screening module, the nutritional evaluation module, the nutritional problem analysis module, the intervention implement module, the intervention effect monitoring module and the effect analysis and evaluation module. The clinical nutrition diagnosis and treatment system can systematically implement clinical nutrition intervention, and the nutritional problem analysis module can divide nutritional problems into three levels of nutritional problems. Thus, the clinical nutrition diagnosis and treatment system can accurately determine nutrition problems and is practical and optimized system tool for implementing nutritional intervention by personal related to clinical nutrition diagnosis and treatment.

The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.

The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.

An early in life nutritional intervention with a lipid component having both large lipid globules with phospholipids and an increased amount of palmitic acid in the sn-2 position in triglycerides werefound to improve the fatty acid composition of cell membranes, in particular brain membranes.

The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.

The invention discloses a nutritional composition for moistening lung and nourishing kidney, and relates to the technical field of health food, the composition is prepared from the following raw material in parts by weight: 30-50 parts of asparagus powder, 15-35 parts of cordyceps polysaccharide powder, 3-20 parts of polygonatum sibiricum powder, 1-10 parts of Chinese wolfberry powder, and 10-30 parts of morchella fungus polysaccharide powder. The nutritional composition for moistening lung and nourishing kidney is deployed according to the main strategy of healthy Chinese prevention first, combines five biological nutrients such as asparagus, cordyceps militaris and the like in combination with the principle of treatment based on the principle of mutual generation and restriction and syndrome differentiation treatment of heart, liver, spleen, lung and kidney in five elements of traditional Chinese medicine, and enhances the immunity and prevents the occurrence of lung diseases in a nutritional intervention manner.

The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.

The invention belongs to the field of functional nutritional food, and in particular relates to a nutritional composition for treating liver cirrhosis and a preparation method thereof. According to the nutritional metabolism characteristics and required nutrients of Chinese liver cirrhosis population, the present invention scientifically formulates a nutritional composition for the treatment of liver cirrhosis, and through reasonable nutritional intervention, improves the nutritional metabolism state of patients with liver disease, promotes liver cell regeneration, and promotes liver regeneration. The recovery of function can effectively improve the biochemical indicators and Child-Pugh score of patients with liver cirrhosis, and improve the quality of life.

The invention discloses a tube feeding clinical nourishment with a blood fat reducing effect. The tube feeding clinical nourishment comprises the following raw materials in parts by weight: 2,000 to 4,000 parts of puffed powder, 500 to 2,000 parts of soybean separation protein, 1,000 to 3,000 parts of maltodextrin, 1,000 to 2,000 parts of milk powder, 500 to 2,000 parts of resistant starch, 100 to 500 parts of black rice bran, 200 to 500 parts of inulin, 200 to 500 parts of polydextrose, 100 to 200 parts of sea bass blood fat-reducing active peptide and 7 to 14 parts of taurine. The invention also discloses a preparation method for the tube feeding clinical nourishment with the blood fat reducing effect. The tube feeding clinical nourishment meets the requirement on tube feeding food, has a blood fat reducing effect, can be used for performing nutritional intervention on severe hyperlipidemia patients; the tube feeding clinical nourishment is rich in nutrition, natural and safe.

The invention discloses a clinical nutrition diagnosis and treatment simulation system, which includes an assessment module, a diagnosis module, an intervention module, a monitoring module and an effect evaluation and analysis module. The clinical nutrition diagnosis and treatment simulation system also includes an intelligent database, which includes an assessment database, a diagnosis Database, intervention database, monitoring database; system users can diagnose according to the diagnosis prompts, and the intelligent database is also provided with an intervention database. The intervention database includes a nutrition analysis model, and the analysis model classifies and refines nutrition problems into three-level nutrition problems, Generate intervention information based on the intervention model. The invention provides a clinical nutrition diagnosis and treatment simulation system, which systematizes the implementation of clinical nutrition intervention, and can be used as a training tool for the behavior development of hospital nutrition diagnosis and treatment personnel; accurately limits nutrition problems; the nutrition problem analysis model can be updated to keep up with the latest in the industry Synchronization of research results.

This invention relates to nutritional compositions comprising at least one fucosylated oligosaccharide, preferably 2FL, for use in enhancing the pancreatic development and / or pancreatic maturation of infants, and / or the enhancement of the insulin biosynthesis and / or the prevention of metabolic disorder or associated diseases and / or glucose management during the nutritional intervention or later in life. The composition can be an infant formula. The composition can also comprise at least one N-acetylated oligosaccharide, preferably LnNT.

The invention relates to biomarkers in the umbilical cord epithelium relating to skin proteins that are better predictive for the development of atopic dermatitis late in life. These biomarkers enable an early nutritional intervention in a more precisely determined population of at risk infants.

The present invention relates in general to the field of muscle disease. In particular, the invention relates to a method for determining if a subject has sarcopenia or has an increased risk of developing sarcopenia. A method of predicting the responsiveness of said subject to nutritional intervention is also provided.

This invention relates to nutritional compositions comprising at least one fucosylated oligosaccharide, preferably 2FL, for use in enhancing the pancreatic development and / or pancreatic maturation of infants, and / or the enhancement of the insulin biosynthesis and / or the prevention of metabolic disorder or associated diseases and / or glucose management during the nutritional intervention or later in life. The composition can be an infant formula. The composition can also comprise at least one N-acetylated oligosaccharide, preferably LnNT.

A nutritional intervention composition for reducing post-prandial blood glucose levels in humans, including between about 0.1 mg and about 10 mg of a proteinase inhibitor that is administered prior to the meal. The composition is effective for treating or ameliorating the effects of hyperglycemia and Type II diabetes. The composition also is effective in combating obesity. The proteinase inhibitor is preferably isolated from plant material, such as potatoes, soy, and beans. Potato proteinase inhibitor II and soybean Bowman-Birk inhibitor are included in the group of effective proteinase inhibitors.